Penumbra, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
PEN New York 3840 www.penumbrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Penumbra, Inc.

Do Options Traders Know Something About Penumbra Stock We Don't? - Nov 10th, 2025 12:26 pm
Penumbra, Inc. Just Recorded A 29% EPS Beat: Here's What Analysts Are Forecasting Next - Nov 8th, 2025 5:52 am
Penumbra price target raised to $355 from $350 at Canaccord - Nov 7th, 2025 6:45 am
Penumbra Shoots For A Breakout On 'Another Impressive Quarter' - Nov 6th, 2025 2:02 pm
Did Strong Q3 Results and Positive CAVT Trial Outcomes Just Shift Penumbra's (PEN) Investment Narrative? - Nov 6th, 2025 11:10 am
Penumbra (PEN) Q3 2025 Earnings Call Transcript - Nov 6th, 2025 9:48 am
Why Penumbra (PEN) Stock Is Up Today - Nov 6th, 2025 9:36 am
Penumbra Inc (PEN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and New Product ... - Nov 5th, 2025 10:03 pm
Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Nov 5th, 2025 4:30 pm
Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates - Nov 5th, 2025 4:00 pm
Penumbra (NYSE:PEN) Delivers Strong Q3 Numbers, Stock Jumps 18.7% - Nov 5th, 2025 3:12 pm
Penumbra: Q3 Earnings Snapshot - Nov 5th, 2025 2:56 pm
Penumbra, Inc. Reports Third Quarter 2025 Financial Results - Nov 5th, 2025 2:05 pm
What To Expect From Penumbra’s (PEN) Q3 Earnings - Nov 3rd, 2025 8:12 pm
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism - Nov 3rd, 2025 1:00 pm
Is Penumbra’s Stock Still a Good Bet After a 7% Drop in the Past Month? - Oct 29th, 2025 12:15 pm
Why Penumbra (PEN) Shares Are Falling Today - Oct 28th, 2025 1:20 pm
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism - Oct 27th, 2025 7:00 am
Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines? - Oct 26th, 2025 3:00 pm
Needham Upgrades Penumbra (PEN) to Buy Amid 2026 Growth Outlook - Oct 20th, 2025 4:31 am